Nuzenio

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 12:23:46 GMTUltragenyx Pharmaceutical's (RARE) Buy Rating Reiterated at HC Wainwright - MarketBeat
Mon, 10 Aug 2026 10:57:39 GMTRARE Reiterated by HC Wainwright & Co. -- Rating Maintained at B - GuruFocus
Mon, 10 Aug 2026 08:46:59 GMTSei Investments Co. Sells 61,632 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Mon, 10 Aug 2026 08:33:04 GMTHow Investors Are Reacting To Ultragenyx Pharmaceutical (RARE) Q2 Revenue Gain And Narrower Net Loss - simplywall.st
Sun, 09 Aug 2026 22:16:37 GMTIs Q2 Revenue Growth And Narrower Loss Altering The Investment Case For Ultragenyx Pharmaceutical (RARE)? - Yahoo! Finance Canada
Sun, 09 Aug 2026 03:22:00 GMTHas Ultragenyx Pharmaceutical (RARE) Fallen Far Enough To Avoid Overvaluation? - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ultragenyx Pharmaceutical.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.